Health ❯ Diseases ❯ Autoimmune Diseases
Symptoms Living with Multiple Sclerosis Treatment Options Inflammation Patient Experiences Selma Blair Genetic Risk Factors Living with MS Personal Experiences Christina Applegate's Experience Stomach Bug Epidemiology Mental Health Awareness and Support Neurological Disorders Egr-1 and Treg Cells Genetic Causes Awareness Events Rheumatoid Arthritis Impact on Families Therapeutic Approaches Epstein-Barr Virus Christina Applegate Awareness Campaigns CAR T Cell Therapy Research Studies Genetic Risk Causes Genetic Variants Geographical Disparity MS Public Figures with MS
The program narrows to non‑relapsing secondary progressive MS, with the U.S. decision now expected by the end of the first quarter of 2026.